SLI
1.986,50
PKT
-7,62
PKT
-0,38
%
Werbung
Analysen zu SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
14.04.22 | UBS Hold | Deutsche Bank AG | |
14.04.22 | Swiss Re Neutral | JP Morgan Chase & Co. | |
14.04.22 | ams-OSRAM Hold | Jefferies & Company Inc. | |
13.04.22 | UBS Neutral | UBS AG | |
13.04.22 | Givaudan Neutral | UBS AG | |
13.04.22 | Givaudan Hold | Deutsche Bank AG | |
13.04.22 | Roche Equal-weight | Morgan Stanley | |
13.04.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
13.04.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
13.04.22 | Givaudan Neutral | JP Morgan Chase & Co. | |
12.04.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
12.04.22 | Givaudan Underweight | Barclays Capital | |
12.04.22 | Givaudan Add | Baader Bank | |
12.04.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
12.04.22 | Roche Neutral | JP Morgan Chase & Co. | |
12.04.22 | Givaudan Neutral | JP Morgan Chase & Co. | |
12.04.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
12.04.22 | Givaudan Underperform | Jefferies & Company Inc. | |
11.04.22 | UBS Underweight | JP Morgan Chase & Co. | |
11.04.22 | Richemont Outperform | RBC Capital Markets | |
11.04.22 | Richemont Buy | Jefferies & Company Inc. | |
08.04.22 | Novartis Neutral | UBS AG | |
07.04.22 | Swiss Re Sell | Goldman Sachs Group Inc. | |
07.04.22 | Swiss Re Sell | UBS AG | |
07.04.22 | Swiss Re Hold | Jefferies & Company Inc. | |
07.04.22 | Swiss Re Neutral | JP Morgan Chase & Co. | |
07.04.22 | ams-OSRAM Hold | Deutsche Bank AG | |
06.04.22 | Nestlé Buy | UBS AG | |
06.04.22 | ams-OSRAM Neutral | UBS AG | |
06.04.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
06.04.22 | Nestlé Overweight | Barclays Capital | |
06.04.22 | ams-OSRAM Underweight | Barclays Capital | |
06.04.22 | ams-OSRAM Hold | Jefferies & Company Inc. | |
05.04.22 | UBS Outperform | RBC Capital Markets | |
05.04.22 | UBS Sector Perform | RBC Capital Markets | |
05.04.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
05.04.22 | ams-OSRAM Neutral | UBS AG | |
05.04.22 | Novartis Sell | Deutsche Bank AG | |
05.04.22 | Richemont Overweight | JP Morgan Chase & Co. | |
04.04.22 | Nestlé Overweight | JP Morgan Chase & Co. |